PLx Pharma Inc.
PLXP · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $69 | $22 | $14 | $14 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $0 | $0 | $0 |
| Inventory | $2 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $0 | $0 | $1 |
| Total Curr. Assets | $73 | $23 | $14 | $15 |
| Property Plant & Equip (Net) | $1 | $2 | $2 | $1 |
| Goodwill | $2 | $2 | $2 | $2 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $3 | $4 | $4 | $4 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $77 | $27 | $19 | $18 |
| Liabilities | – | – | – | – |
| Payables | $11 | $1 | $1 | $1 |
| Short-Term Debt | $0 | $1 | $4 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $2 | $1 | $0 |
| Other Curr. Liab. | $1 | $0 | $0 | $1 |
| Total Curr. Liab. | $12 | $4 | $6 | $5 |
| LT Debt | $0 | $0 | $1 | $4 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $13 | $13 | $10 | $3 |
| Total NC Liab. | $13 | $13 | $11 | $7 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $25 | $16 | $17 | $12 |
| Equity | – | – | – | – |
| Pref Stock | $16 | $21 | $14 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$148 | -$102 | -$87 | -$66 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $184 | $91 | $75 | $73 |
| Total Equity | $52 | $10 | $2 | $6 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $77 | $27 | $19 | $18 |
| Net Debt | -$69 | -$22 | -$10 | -$7 |